Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-23-051460

Options or other derivatives

  • Director acquired 150,437 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Robinson James A. Jr. · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-10-02 Grant or award : show line 1 in the form Stock Option (Right to Buy) +150,437 $1.55 $233,177 150,437 D
Loading xslF345X05/doc4.xml…